11/18/2024
4:54 PM | Atara Biotherapeutics (Subject)
Henrich Jill (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/18/2024
4:55 PM | Atara Biotherapeutics (Subject)
Hyllengren Eric J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/18/2024
4:56 PM | Atara Biotherapeutics (Subject)
Murugan Amar (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/18/2024
4:58 PM | Atara Biotherapeutics (Subject)
Nguyen AnhCo (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
5:10 PM | Atara Biotherapeutics (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SC 13G/A | |
11/12/2024
12:29 PM | Atara Biotherapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
10:24 AM | Atara Biotherapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
|
10/15/2024
3:05 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2024
4:03 PM | Atara Biotherapeutics (Issuer)
Nguyen AnhCo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
5:42 PM | Adiumentum Capital Fund I GP LLC (Reporting)
Adiumentum Capital Fund I LP (Reporting)
Atara Biotherapeutics (Issuer)
Ciongoli Gregory Austin (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/05/2024
3:07 PM | Adiumentum Capital Fund I LP (Filed by)
Atara Biotherapeutics (Subject)
| Form SC 13D/A | |
09/04/2024
3:42 PM | Atara Biotherapeutics (Filer)
| Form 424B5 | |
09/03/2024
4:05 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2024
5:26 PM | Atara Biotherapeutics (Issuer)
Henrich Jill (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
5:27 PM | Atara Biotherapeutics (Issuer)
Hyllengren Eric J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
5:27 PM | Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
5:27 PM | Atara Biotherapeutics (Issuer)
Nguyen AnhCo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
5:27 PM | Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
5:00 PM | Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
4:10 PM | Atara Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
4:05 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2024
3:16 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
3:32 PM | Atara Biotherapeutics (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
06/20/2024
4:04 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
7:30 AM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2024
5:18 PM | Adiumentum Capital Fund I LP (Filed by)
Atara Biotherapeutics (Subject)
| Form SC 13D | |
05/20/2024
7:32 PM | Atara Biotherapeutics (Issuer)
Henrich Jill (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
7:33 PM | Atara Biotherapeutics (Issuer)
Hyllengren Eric J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
7:33 PM | Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
7:34 PM | Atara Biotherapeutics (Issuer)
Nguyen AnhCo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
7:34 PM | Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
8:13 PM | Atara Biotherapeutics (Subject)
Henrich Jill (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
8:13 PM | Atara Biotherapeutics (Subject)
Hyllengren Eric J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
8:14 PM | Atara Biotherapeutics (Subject)
Murugan Amar (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
8:14 PM | Atara Biotherapeutics (Subject)
Nguyen AnhCo (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
8:15 PM | Atara Biotherapeutics (Subject)
Touchon Pascal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
7:55 PM | Atara Biotherapeutics (Subject)
Nguyen AnhCo (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/26/2024
3:20 PM | Atara Biotherapeutics (Filer)
| Form DEFA14A | |
04/26/2024
3:15 PM | Atara Biotherapeutics (Filer)
| Form DEF 14A | |
04/12/2024
3:15 PM | Atara Biotherapeutics (Filer)
Atara Biotherapeutics (Filer)
| Form PRE 14A | |
04/02/2024
5:11 PM | Atara Biotherapeutics (Issuer)
MALLIK AMEET (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad) It's a groundbreaking opportunity that could be poised for extraordinary gains.
The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW |
04/02/2024
5:12 PM | Atara Biotherapeutics (Issuer)
Gallagher Carol Giltner (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
5:12 PM | Atara Biotherapeutics (Issuer)
Roncarolo Maria Grazia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
5:12 PM | Atara Biotherapeutics (Issuer)
HEIDEN WILLIAM K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
5:13 PM | Atara Biotherapeutics (Issuer)
Fust Matthew K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2024
3:30 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
7:40 AM | Atara Biotherapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/28/2024
7:35 AM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
5:18 PM | Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:18 PM | Atara Biotherapeutics (Issuer)
Nguyen AnhCo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:19 PM | Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:16 PM | Atara Biotherapeutics (Issuer)
Henrich Jill (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:17 PM | Atara Biotherapeutics (Issuer)
Hyllengren Eric J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
7:17 PM | Atara Biotherapeutics (Subject)
Murugan Amar (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
7:18 PM | Atara Biotherapeutics (Subject)
Hyllengren Eric J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
7:19 PM | Atara Biotherapeutics (Subject)
Henrich Jill (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
7:21 PM | Atara Biotherapeutics (Subject)
Touchon Pascal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
7:13 PM | Atara Biotherapeutics (Subject)
Nguyen Tran (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/23/2024
3:30 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/06/2024
3:45 PM | Atara Biotherapeutics (Subject)
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
| Form SC 13G/A | |
01/22/2024
12:58 PM | Atara Biotherapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/09/2024
3:40 PM | Atara Biotherapeutics (Issuer)
Henrich Jill (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
3:40 PM | Atara Biotherapeutics (Issuer)
Hyllengren Eric J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
3:40 PM | Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
3:40 PM | Atara Biotherapeutics (Issuer)
Nguyen AnhCo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
3:41 PM | Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
3:28 PM | Atara Biotherapeutics (Filer)
| Form 424B5 | |
01/09/2024
3:22 PM | Atara Biotherapeutics (Subject)
BAUPOST GROUP LLC/MA (Filed by)
| Form SC 13G/A | |
01/08/2024
7:11 AM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2023
3:30 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/07/2023
1:45 PM | Atara Biotherapeutics (Subject)
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
| Form SC 13G/A | |
11/20/2023
4:31 PM | Atara Biotherapeutics (Issuer)
Nguyen AnhCo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
4:31 PM | Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
4:29 PM | Atara Biotherapeutics (Issuer)
Henrich Jill (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
4:29 PM | Atara Biotherapeutics (Issuer)
Hyllengren Eric J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
4:30 PM | Atara Biotherapeutics (Issuer)
Joshi Manher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
4:30 PM | Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
